A Study of Safety and Immunogenicity of a Malaria Vaccine Candidate
Clinical trial NCT00284973 · COMPLETED
Trial details
- NCT number
- NCT00284973
- Sponsor
- Shanghai Wanxing Bio-Pharmaceutical Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.